Larotaxel
From Self-sufficiency
| File:Larotaxel.png | |
| Systematic (IUPAC) name | |
|---|---|
|
(2α,3ξ,4α,5β,7α,10β,13α)-4,10-bis(acetyloxy)-13-({(2R,3S)-3-
[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1- hydroxy-9-oxo-5,20-epoxy-7,19-cyclotax-11-en-2-yl benzoate | |
| Identifiers | |
| CAS Number | 156294-36-9 |
| ATC code | none |
| PubChem | CID 6918260 |
| Chemical data | |
| Formula | C45H57NO16 |
| Molar mass | 867.93 g/mol[[Script error: No such module "String".]] |
Larotaxel is a drug of the taxan type, used in chemotherapy.
| 40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Chemotherapeutic agents
- Antineoplastic and immunomodulating drug stubs
